Systemic Juvenile Idiopathic Arthritis Therapeutics Assessment. Major key companies such as Chugai Pharmaceutical, AstraZeneca, Pfizer, Incyte Corporation Novartis, Roche, ...

Medically reviewed by Anita C. Chandrasekaran, MDMedically reviewed by Anita C. Chandrasekaran, MD Juvenile idiopathic arthritis (JIA) is arthritis that affects children and whose cause is unknown ...

Your child has systemic juvenile idiopathic arthritis. Systemic JIA is one of the seven subtypes of arthritis that are included under the umbrella term of juvenile idiopathic -- meaning having an ...

Interleukin-1 is pivotal in the pathogenesis of systemic juvenile idiopathic arthritis (JIA). We assessed the efficacy and safety of canakinumab, a selective, fully human, anti–interleukin-1β ...

More information: Bruno Fautrel et al, EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's ...

About 30% of all children with juvenile idiopathic arthritis have this type. It usually affects the small joints, like those in the hands and feet, but it can sometimes involve the large joints.

Systemic juvenile idiopathic arthritis (sJIA) is defined as arthritis that occurs in children aged 16 years or younger, and is accompanied by a quotidian fever of 39°C or higher that persists for ...

Juvenile idiopathic arthritis affects children under age 16. Learn about common symptoms such as joint problems, fatigue, loss of appetite, and more.

Systemic-onset juvenile idiopathic arthritis (SJIA) is rare but it can be a devastating disease that responds poorly to therapy. Case series have suggested that the interleukin-1 receptor ...

1 Appraisal Committee’s preliminary recommendations. 1.1 Tocilizumab is not recommended for the treatment of systemic juvenile idiopathic arthritis in children and young people aged 2 to 17 years and ...

More information: Bruno Fautrel et al, EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's ...